Comprehensive Evaluation of One-Carbon Metabolism Pathway Gene Variants and Renal Cell Cancer Risk

• Todd M. Gibson ,

  * E-mail: gibsontm@mail.nih.gov

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America, Yale School of Public Health, New Haven, Connecticut, United States of America

  ⨯
• Paul Brennan,

  Affiliation International Agency for Research on Cancer, Lyon, France

  ⨯
• Summer Han,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Sara Karami,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• David Zaridze,

  Affiliation Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russia

  ⨯
• Vladimir Janout,

  Affiliation Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic

  ⨯
• Helen Kollarova,

  Affiliation Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic

  ⨯
• Vladimir Bencko,

  Affiliation 1st Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic

  ⨯
• Marie Navratilova,

  Affiliation Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic

  ⨯
• Neonila Szeszenia-Dabrowska,

  Affiliation Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland

  ⨯
• Dana Mates,

  Affiliation Institute of Public Health, Bucharest, Romania

  ⨯
• Alena Slamova,

  Affiliation 1st Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic

  ⨯
• Ruth M. Pfeiffer,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Rachael Z. Stolzenberg-Solomon,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Susan T. Mayne,

  Affiliation Yale School of Public Health, New Haven, Connecticut, United States of America

  ⨯
• Meredith Yeager,

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America, Core Genotyping Facility, National Cancer Institute, Gaithersburg, Maryland, United States of America

  ⨯
• Stephen Chanock,

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America, Core Genotyping Facility, National Cancer Institute, Gaithersburg, Maryland, United States of America

  ⨯
• Nat Rothman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Wong-Ho Chow,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Philip S. Rosenberg,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Paolo Boffetta,

  Affiliations International Agency for Research on Cancer, Lyon, France, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America, International Cancer Prevention Research Institute, Lyon, France

  ⨯
•  [ ... ],
• Lee E. Moore

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]